Alpha 2.0
Login Register
» Authors » F Al Sharif

F Al Sharif

Explore the profile of F Al Sharif including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 61
Followers 0
Related Specialties
Allergy & Immunology
General Surgery
Oncology
Top 10 Co-Authors
A Al Shanqeeti
H Al Zahrani
W E Ollier
F Al Mohareb
A H Hajeer
M Aljurf
E Sahovic
N Chaudhri
P Seth
H Al Omar
Published In
Eur J Immunogenet
Bone Marrow Transplant
Clin Exp Rheumatol
Med Oncol
Hematology
Affiliations
Soon will be listed here.
Recent Articles
1.
High efficacy and low toxicity of APL induction with concurrent idarubicin/ATRA followed by a novel and simplified outpatient post-remission therapy using single doses of idarubicin and intermittent ATRA
Aljurf M, Al Qurashi F, Al Mohareb F, Sahovic E, Al Sharif F, Al Zahrani H, et al.
Med Oncol . 2009 Aug; 27(3):702-7. PMID: 19669610
Acute promyelocytic leukemia (APL) is one of the most curable myeloid malignancies because of its great sensitivity to all-trans retinoic acid (ATRA) and response to anthracycline therapy. In an attempt...
2.
Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic hematopoietic stem cell transplantation by early administration of a short course of methylprednisolone
Al Beihany A, Al Omar H, Sahovic E, Chaudhri N, Al Mohareb F, Al Sharif F, et al.
Bone Marrow Transplant . 2007 Nov; 41(3):287-91. PMID: 17982501
Hepatic veno-occlusive disease (VOD) is one of the most common and important regimen-related toxicities observed after hematopoietic stem cell transplantation (HSCT). There are no universally accepted preventative or therapeutic approaches...
3.
Second allogeneic bone marrow transplantation after myeloablative conditioning analysis of 43 cases from single institution
Al-Qurashi F, Ayas M, Al Sharif F, Ibrahim E, Sahovic E, Al Mahr M, et al.
Hematology . 2004 Jun; 9(2):123-9. PMID: 15203867
Between March 1984 and December 1999, a total of 43 second related allogeneic BMT procedures after myeloablative conditioning were carried out in our institution, 37 following allogeneic, and 6 following...
4.
RANTES gene polymorphism in polymyalgia rheumatica, giant cell arteritis and rheumatoid arthritis
Makki R, Al Sharif F, Gonzalez-Gay M, Garcia-Porrua C, Ollier W, Hajeer A
Clin Exp Rheumatol . 2000 Jul; 18(3):391-3. PMID: 10895380
Objective: To investigate whether a biallelic polymorphism (A or G) occurring within the promoter region of the RANTES gene (position-403) is associated with polymyalgia rheumatica (PMR), giant cell arteritis (GCA)...
5.
A polymorphism at position -403 in the human RANTES promoter
Hajeer A, Al Sharif F, Ollier W
Eur J Immunogenet . 1999 Dec; 26(5):375-6. PMID: 10553505
No abstract available.
6.
A rare polymorphism at position -28 in the human RANTES promoter
Al Sharif F, Ollier W, Hajeer A
Eur J Immunogenet . 1999 Dec; 26(5):373-4. PMID: 10553504
No abstract available.